IL161765A0 - P85-alpha nucleic acids, polypeptides and related methods - Google Patents
P85-alpha nucleic acids, polypeptides and related methodsInfo
- Publication number
- IL161765A0 IL161765A0 IL16176502A IL16176502A IL161765A0 IL 161765 A0 IL161765 A0 IL 161765A0 IL 16176502 A IL16176502 A IL 16176502A IL 16176502 A IL16176502 A IL 16176502A IL 161765 A0 IL161765 A0 IL 161765A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptides
- nucleic acids
- related methods
- alpha nucleic
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70585—CD44
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34588501P | 2001-11-09 | 2001-11-09 | |
PCT/US2002/035989 WO2003060067A2 (en) | 2001-11-09 | 2002-11-08 | P85-alpha nucleic acids, polypeptides and related methods |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161765A0 true IL161765A0 (en) | 2005-11-20 |
Family
ID=23356927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16176502A IL161765A0 (en) | 2001-11-09 | 2002-11-08 | P85-alpha nucleic acids, polypeptides and related methods |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002365189A1 (en) |
IL (1) | IL161765A0 (en) |
WO (1) | WO2003060067A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017950A2 (en) * | 2002-08-22 | 2004-03-04 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
US20120039905A1 (en) * | 2009-01-13 | 2012-02-16 | The Babraham Institute | The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection |
US10123991B2 (en) * | 2015-05-15 | 2018-11-13 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
US10966954B2 (en) | 2016-05-16 | 2021-04-06 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537972B1 (en) * | 1997-06-02 | 2003-03-25 | Subsidiary No. 3., Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
-
2002
- 2002-11-08 IL IL16176502A patent/IL161765A0/en unknown
- 2002-11-08 WO PCT/US2002/035989 patent/WO2003060067A2/en not_active Application Discontinuation
- 2002-11-08 AU AU2002365189A patent/AU2002365189A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002365189A1 (en) | 2003-07-30 |
AU2002365189A8 (en) | 2003-07-30 |
WO2003060067A2 (en) | 2003-07-24 |
WO2003060067A3 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1504099A4 (en) | Novel nucleic acids and polypeptides | |
EP1381621A4 (en) | Novel nucleic acids and polypeptides | |
EP1432800A4 (en) | Novel nucleic acids and polypeptides | |
EP1470238A4 (en) | Novel nucleic acids and polypeptides | |
AU2001234944A8 (en) | Novel nucleic acids and polypeptides | |
EP1325120A4 (en) | Novel nucleic acids and polypeptides | |
EP1430112A4 (en) | Novel nucleic acids and polypeptides | |
EP1556490A4 (en) | Novel nucleic acids and polypeptides | |
EP1341804A4 (en) | Novel nucleic acids and polypeptides | |
EP1368475A4 (en) | Novel nucleic acids and polypeptides | |
EP1276751A4 (en) | Novel nucleic acids and polypeptides | |
AU2002256461A8 (en) | Polypeptides and nucleic acids associated with cancer | |
AU2003262789A8 (en) | Abca13 nucleic acids and proteins, and uses thereof | |
EP1341803A4 (en) | Novel nucleic acids and polypeptides | |
EP1383533A4 (en) | Proteins and nucleic acids encoding same | |
AU2003234274A8 (en) | D1-1 nucleic acids, polypeptides and related methods | |
PL379564A1 (en) | Btl-ii nucleic acids, proteins, and antibodies | |
IL161765A0 (en) | P85-alpha nucleic acids, polypeptides and related methods | |
EP1409683A4 (en) | i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF | |
AU2002250419A1 (en) | Novel nucleic acids and polypeptides | |
AU2001263005A8 (en) | Novel nucleic acids and polypeptides | |
EP1268762A4 (en) | Novel nucleic acids and polypeptides | |
AU2003225036A8 (en) | Cancer-associated nucleic acids and polypeptides | |
AU7005801A (en) | Gp354 nucleic acids and polypeptides | |
EP1274716A4 (en) | Novel nucleic acids and polypeptides |